Morgan Stanley is a buy, driven by accelerating earnings growth with FY25E EPS of $10.20, a 28% jump from $7.95 in FY24, powered by robust investment banking and wealth management. Despite a 13% YTD rally, the stock trades at 17.4x earnings, a modest premium to GS but a 49% discount on EV/EBITDA, suggesting undervaluation relative to its closest peer. Smart money accumulation jumped sharply in Q1 2026, offsetting recent insider profit-taking, while the price remains in a firm uptrend above its 50- and 200-day moving averages.
Insider Selling Cluster
Senior executives including Co-Presidents and CFO sold significant shares in April 2026 near $188-$191, signaling potential near-term caution.
Overbought Technicals
14-day RSI at 68.3 nears overbought territory, increasing the probability of a short-term pullback after the strong YTD run.
Leverage Increase
Total debt is projected to rise from $360.5B in FY24 to $475.6B in FY25E, elevating financial risk if earnings or funding conditions deteriorate.
Capital Markets Sensitivity
Revenue remains highly dependent on M&A advisory and trading activity, which could decline in an economic downturn or risk-off environment.